Journey Medical Corp’s recent filing unveils that its President & CEO Maraoui Claude unloaded Company’s shares for reported $33065.0 on May 02 ’25. In the deal valued at $6.84 per share,4,834 shares were sold. As a result of this transaction, Maraoui Claude now holds 2,348,313 shares worth roughly $20.05 million.
Then, Benesch Joseph sold 2,409 shares, generating $16,478 in total proceeds. Upon selling the shares at $6.84, the CFO now owns 203,557 shares.
Before that, Alloush Ramsey sold 2,857 shares. Journey Medical Corp shares valued at $19,542 were divested by the COO at a price of $6.84 per share. As a result of the transaction, Alloush Ramsey now holds 504,817 shares, worth roughly $4.31 million.
A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. B. Riley Securities started covering the stock on December 07, 2021. It rated DERM as “a Buy”.
Price Performance Review of DERM
On Tuesday, Journey Medical Corp [NASDAQ:DERM] saw its stock jump 8.51% to $8.54. Over the last five days, the stock has gained 18.45%. Journey Medical Corp shares have risen nearly 72.18% since the year began. Nevertheless, the stocks have risen 118.41% over the past one year. While a 52-week high of $8.25 was reached on 08/12/25, a 52-week low of $3.54 was recorded on 01/22/25.
Levels Of Support And Resistance For DERM Stock
The 24-hour chart illustrates a support level at 7.87, which if violated will result in even more drops to 7.21. On the upside, there is a resistance level at 9.05. A further resistance level may holdings at 9.57.
How much short interest is there in Journey Medical Corp?
A steep rise in short interest was recorded in Journey Medical Corp stocks on 2025-07-31, growing by 0.22 million shares to a total of 1.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 0.98 million shares. There was a rise of 18.54%, which implies that there is a positive sentiment for the stock.
